← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

eHealth, Inc. (EHTH) 10-Year Financial Performance & Capital Metrics

EHTH • • Insurance & Managed Care
Financial ServicesInsurance BrokersDigital Health Insurance MarketplacesMulti-Product Health Marketplaces
AbouteHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company operates a marketplace that offers consumers a choice of insurance products, such as Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business, and other ancillary health insurance products from health insurance carriers. It markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers to market and distribute health insurance plans online; and provides online sponsorship and advertising, and lead referral services. eHealth, Inc. was incorporated in 1997 and is headquartered in Santa Clara, California.Show more
  • Revenue $532M +17.6%
  • Combined Ratio 95.57% -10.2%
  • Net Income $10M +135.6%
  • Return on Equity 1.35% +137.1%
  • Medical Cost Ratio 0.34% -13.8%
  • Operating Margin 4.43% +169.0%
  • Net Margin 1.89% +130.3%
  • ROA 0.89% +135.0%
  • Equity / Assets 50.93% -37.3%
  • Book Value per Share 20.06 -37.8%
  • Tangible BV/Share 20.06 -36.2%
  • Debt/Equity 0.16 +44.4%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Low loss ratio of 0.3%
  • ✓Healthy dividend yield of 4.9%
  • ✓Trading at only 0.2x book value

✗Weaknesses

  • ✗Profits declining 31.5% over 5 years
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.47%
5Y1.01%
3Y-0.36%
TTM16.79%

Profit (Net Income) CAGR

10Y-
5Y-31.54%
3Y-
TTM242.88%

EPS CAGR

10Y-
5Y-
3Y-
TTM101.4%

ROCE

10Y Avg-0.71%
5Y Avg-3.17%
3Y Avg-3.4%
Latest2.25%

Peer Comparison

Multi-Product Health Marketplaces
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
EHTHeHealth, Inc.118.14M3.84-3.2317.56%9.27%5.69%0.16

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+189.54M193.32M190.71M251.4M506.2M582.77M538.2M405.36M452.87M532.41M
Revenue Growth %0.05%0.02%-0.01%0.32%1.01%0.15%-0.08%-0.25%0.12%0.18%
Medical Costs & Claims+4.18M862K582K1.23M2.74M4.08M1.99M1.65M1.77M1.79M
Medical Cost Ratio %----------
Gross Profit+185.36M192.46M190.12M250.17M503.46M578.69M536.21M403.71M451.1M530.62M
Gross Margin %----------
Gross Profit Growth %0.06%0.04%-0.01%0.32%1.01%0.15%-0.07%-0.25%0.12%0.18%
Operating Expenses+191.01M189.64M199.58M247.62M422.05M525.37M661.85M506.42M480.17M507.05M
OpEx / Revenue %----------
Depreciation & Amortization5.93M5.51M5.34M6.77M8.99M12.94M18.87M21.11M19.92M16.34M
Combined Ratio %----------
Operating Income+-5.65M2.82M-9.45M2.55M81.41M53.32M-125.64M-102.71M-29.07M23.57M
Operating Margin %----------
Operating Income Growth %0.16%1.5%-4.35%1.27%30.91%-0.34%-3.36%0.18%0.72%1.81%
EBITDA+277K8.34M-4.11M9.32M90.4M66.27M-106.78M-81.61M-9.16M39.91M
EBITDA Margin %----------
Interest Expense000000845K7.63M10.97M11.16M
Non-Operating Income-4.54M297K-621K-14.24M-24.08M0-1.6M-3.95M-9.45M-6.9M
Pretax Income+-5.61M3.97M-8.27M3.31M83.5M53.99M-124.89M-106.39M-30.59M19.31M
Pretax Margin %----------
Income Tax+-843K3.67M-33.7M3.06M16.61M8.54M-20.52M-17.67M-2.38M9.26M
Effective Tax Rate %----------
Net Income+-4.76M304K25.43M241K66.89M45.45M-104.38M-88.72M-28.21M10.06M
Net Margin %----------
Net Income Growth %0.71%1.06%82.64%-0.99%276.54%-0.32%-3.3%0.15%0.68%1.36%
EPS (Diluted)+-0.26-0.271.330.012.731.68-3.90-4.36-2.37-1.19
EPS Growth %0.7%-0.04%5.93%-0.99%230.36%-0.38%-3.32%-0.12%0.46%0.5%
EPS (Basic)-0.26-0.271.370.012.901.75-3.90-4.36-2.37-1.19
Diluted Shares Outstanding18.01M18.27M19.05M20.41M24.54M27.01M26.78M27.36M28.02M29.34M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+113.32M108.9M359.12M439.28M741.63M1.04B1.15B1.11B1.11B1.16B
Asset Growth %0.06%-0.04%2.3%0.22%0.69%0.4%0.11%-0.03%0%0.04%
Total Investment Assets+-204K-204K170.3M211.44M049.62M41.31M05.93M43.04M
Long-Term Investments-204K-204K170.3M211.44M000000
Short-Term Investments0000049.62M41.31M05.93M43.04M
Total Current Assets+77.54M76.14M155.74M156.17M208.15M330.99M407.59M401.08M382.35M354.48M
Cash & Equivalents62.71M61.78M40.29M13.09M23.47M43.76M81.93M144.4M115.72M39.2M
Receivables1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Assets2.79M2.21M1.56M2.87M260K646K922K223K733K1.32M
Goodwill & Intangibles+23.72M22.68M21.64M52.48M50.3M48.8M1.92M023.6M0
Goodwill14.1M14.1M14.1M40.23M40.23M40.23M0000
Intangible Assets9.62M8.58M7.54M12.25M10.06M8.57M1.92M023.6M0
PP&E (Net)7.36M5.61M4.71M7.68M47.14M57.17M49.48M32.02M27.63M16.52M
Other Assets4.7M4.47M6.51M11.28M435.79M603.06M690.3M679.51M679.76M784.43M
Total Liabilities36.9M31.3M72.45M136.13M214.47M202.46M399.77M461.66M209.26M567M
Total Debt+02.01M3.39M5M39.06M46.56M41.37M106.8M103.16M96.92M
Net Debt-62.71M-59.77M-36.9M-8.09M15.6M2.8M-40.56M-37.6M-12.56M57.72M
Long-Term Debt0005M00066.13M67.75M68.46M
Short-Term Debt0000000000
Total Current Liabilities+31.94M27.92M25.45M60.62M112.98M84.41M75.47M60.56M78.54M96.01M
Accounts Payable3.01M5.11M3.25M5.69M24.55M36.92M13.75M6.73M7.2M23.45M
Deferred Revenue392K959K385K876K2.57M308K0000
Other Current Liabilities00023.16M69.06M24.2M19.79M23.58M43.93M48.22M
Deferred Taxes329K443K1000K1000K1000K1000K1000K1000K01000K
Other Liabilities4.63M2.93M1.92M22.61M3.05M4.37M237.69M268.42M34.64M342.93M
Total Equity+76.42M15.82M246.37M295.06M527.16M837.56M749.52M650.96M904.08M588.43M
Equity Growth %0.04%-0.79%14.57%0.2%0.79%0.59%-0.11%-0.13%0.39%-0.35%
Shareholders Equity76.42M77.6M286.66M303.15M527.16M837.56M749.52M650.96M904.08M588.43M
Minority Interest0-61.78M-40.29M-8.09M000000
Retained Earnings9.5M4.62M204.72M204.97M271.85M316.15M193.21M73.8M7.28M15.25M
Common Stock29K29K30K31K35K38K39K40K41K43K
Accumulated OCI193K176K202K127K116K350K390K-73K-82K-234K
Return on Equity (ROE)-0.06%0.01%0.19%0%0.16%0.07%-0.13%-0.13%-0.04%0.01%
Return on Assets (ROA)-0.04%0%0.11%0%0.11%0.05%-0.1%-0.08%-0.03%0.01%
Equity / Assets----------
Debt / Equity-0.13x0.01x0.02x0.07x0.06x0.06x0.16x0.11x0.16x
Book Value per Share4.240.8712.9314.4621.4831.0027.9923.7932.2720.06
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+13.7M4.08M-15.54M-3.23M-71.49M-107.86M-162.62M-26.87M-6.69M-18.37M
Operating CF Growth %6.7%-0.7%-4.81%0.79%-21.13%-0.51%-0.51%0.83%0.75%-1.74%
Operating CF / Revenue %----------
Net Income-4.76M-4.88M25.43M241K66.89M45.45M-104.38M-88.72M-28.21M10.06M
Depreciation & Amortization5.93M5.51M5.34M6.77M8.99M12.94M18.87M21.11M19.92M16.34M
Stock-Based Compensation7M7.27M9.69M12.54M22.57M25.17M32.86M20.32M23.21M19.88M
Deferred Taxes101K114K-30.34M2.81M16.2M8.82M-21.52M-18.44M-2.67M9.18M
Other Non-Cash Items2.11M1.42M-101K12.97M23.32M1.09M47.81M14.19M701K7.91M
Working Capital Changes3.32M-5.35M-25.56M-38.57M-209.46M-201.33M-136.26M24.68M-19.64M-81.73M
Cash from Investing+-3M-3.73M-5.08M-25.76M-16.94M-73.28M-12.63M25.86M-15.89M-48.42M
Capital Expenditures-3M-3.73M-5.08M-10.83M-16.87M-23.76M-20.86M-15.51M-2.09M0
Acquisitions000-14.93M016M16.99M15.51M00
Purchase of Investments00000-180.5M-103.06M-8.4M-54.51M-96.98M
Sale/Maturity of Investments000001000K1000K1000K1000K1000K
Other Investing-1.12M-1.84M-3.21M-6.29M-72K-16M-16.99M-15.51M-8.69M-12.86M
Cash from Financing+577K-1.27M-870K1.86M102.14M201.25M213.24M63.84M-6.22M-9.67M
Dividends Paid00000000-3.53M-5.56M
Share Repurchases-922K-1.25M-1.8M-4.5M-14.28M-19.81M-9.33M-3.1M-3.33M-3.41M
Stock Issued0000126.05M228.02M0000
Debt Issuance (Net)-73K-83K-105K1000K-1000K-157K-150K1000K-38K-4K
Other Financing1.57M62K1.04M1.47M-4.52M-6.81M8.7M2.21M677K-696K
Net Change in Cash+11.29M-929K-21.49M-27.2M13.73M20.29M38.05M62.48M-28.83M-76.53M
Exchange Rate Effect18K-17K1K-77K26K187K64K-355K-19K-64K
Cash at Beginning51.41M62.71M61.78M40.29M13.09M26.82M47.11M85.17M147.64M118.81M
Cash at End62.71M61.78M40.29M13.09M26.82M47.11M85.17M147.64M118.81M42.29M
Free Cash Flow+10.7M357K-20.62M-14.06M-88.36M-131.62M-183.48M-42.38M-17.47M-31.22M
FCF Growth %2.69%-0.97%-58.76%0.32%-5.29%-0.49%-0.39%0.77%0.59%-0.79%
FCF Margin %----------
FCF per Share0.590.02-1.08-0.69-3.6-4.87-6.85-1.55-0.62-1.06

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio102.98%98.54%104.96%98.99%83.92%90.85%123.35%125.34%106.42%95.57%
Medical Cost Ratio2.2%0.45%0.31%0.49%0.54%0.7%0.37%0.41%0.39%0.34%
Return on Equity (ROE)-6.35%0.66%19.39%0.09%16.27%6.66%-13.15%-12.67%-3.63%1.35%
Return on Assets (ROA)-4.33%0.27%10.87%0.06%11.33%5.1%-9.54%-7.84%-2.54%0.89%
Equity / Assets67.44%14.53%68.6%67.17%71.08%80.53%65.22%58.51%81.2%50.93%
Book Value / Share4.240.8712.9314.4621.483127.9923.7932.2720.06
Debt / Equity-0.13x0.01x0.02x0.07x0.06x0.06x0.16x0.11x0.16x
Revenue Growth5.49%2%-1.35%31.82%101.36%15.13%-7.65%-24.68%11.72%17.56%

Revenue by Segment

201620172018201920202021202220232024
Commission---466.68M---403.92M461.65M
Commission Growth--------14.29%
Medicare----436.42M425.5M318.15M360.85M427.35M
Medicare Growth------2.50%-25.23%13.42%18.43%
Product and Service, Other---39.52M74.58M45.08M44.11M48.95M70.76M
Product and Service, Other Growth----88.70%-39.56%-2.15%10.97%44.57%
Small Business----9.57M10.72M11.84M17.67M11.54M
Small Business Growth-----12.04%10.47%49.21%-34.66%
Ancillaries----27.14M21.35M11.47M10.75M10.79M
Ancillaries Growth------21.31%-46.31%-6.21%0.31%
Individual and Family----26.67M32.87M17.86M16.66M8.4M
Individual and Family Growth-----23.27%-45.66%-6.75%-49.57%
Commission Bonus----8.4M2.67M1.92M-2.01M3.56M
Commission Bonus Growth------68.21%-28.05%-204.79%277.05%
Medicare80.27M102.58M210.57M------
Medicare Growth-27.80%105.27%------
Individual, Family, And Small Businesss106.69M69.77M40.83M------
Individual, Family, And Small Businesss Growth--34.60%-41.49%------

Frequently Asked Questions

Growth & Financials

eHealth, Inc. (EHTH) grew revenue by 17.6% over the past year. This is strong growth.

Yes, eHealth, Inc. (EHTH) is profitable, generating $50.3M in net income for fiscal year 2024 (1.9% net margin).

Dividend & Returns

Yes, eHealth, Inc. (EHTH) pays a dividend with a yield of 4.94%. This makes it attractive for income-focused investors.

eHealth, Inc. (EHTH) has a return on equity (ROE) of 1.3%. This is below average, suggesting room for improvement.

Industry Metrics

eHealth, Inc. (EHTH) has a combined ratio of 95.6%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.